Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment[1].
Purity:
95
Target:
SARS-CoV
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted